LubriShieldTM—A permanent urinary catheter coating that prevents uropathogen biofilm formation in vitro independent of host protein conditioning Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1371/journal.pone.0328167
Catheter-associated urinary tract infection is one of the most common healthcare-associated infections, with biofilm formation playing a key role in its pathogenesis. Indwelling medical devices introduce ideal pathways inside the body for pathogens and feature surfaces conducive to biofilm development, often leading to severe clinical infections recalcitrant to antimicrobials. When bacteria and fungi switch to biofilm mode of growth, they produce a matrix in the form of extracellular polymeric substances (EPS). This creates a unique environment for growing virulent colonisers and persisting cells while forming a shielding barrier against immune system attacks, antimicrobial agents and mechanical removal by fluid shear forces. To address this challenge, LubriShield TM – a novel permanent coating – was invented and evenly applied to both internal and external surfaces of indwelling urinary Foley catheters. Without releasing active substances, it effectively prevented pathogens from producing biofilm. The superhydrophilic coating, incorporating a proprietary anti-fouling ligand, significantly inhibited colonising uropathogens from forming biofilm for up to 14 days in artificial urine medium without microbial killing (up to 99% reduction, P < 0.001 ). In a glass bladder flow model, LubriShield TM still significantly reduced biofilm formation by 83 % (P < 0.0001) . Importantly, LubriShield™ maintained its antibiofilm efficacy even after conditioning with fibrinogen, a host-derived protein known to promote bacterial attachment ( P = 0.007 ). RNA-seq analysis revealed significant downregulation of genes associated with microbial EPS formation on the coated surfaces. Additionally, microorganisms adhering to LubriShield TM coated catheters showed a 78% increased susceptibility to antibiotics compared to those on uncoated catheters ( P = 0.004 ).
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1371/journal.pone.0328167
- OA Status
- gold
- References
- 57
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4412164474
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4412164474Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1371/journal.pone.0328167Digital Object Identifier
- Title
-
LubriShieldTM—A permanent urinary catheter coating that prevents uropathogen biofilm formation in vitro independent of host protein conditioningWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-07-10Full publication date if available
- Authors
-
Ana I. Romero, Serhiy Surkov, Per Wirsén, Graham Brookes, Linda Bergström, Jan Tejbrant, Elena Dhamo, Sandra Wilks, Catherine Bryant, Jan AnderssonList of authors in order
- Landing page
-
https://doi.org/10.1371/journal.pone.0328167Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1371/journal.pone.0328167Direct OA link when available
- Concepts
-
Biofilm, In vitro, Urinary catheter, Microbiology, Chemistry, Conditioning, Urinary system, Host (biology), Medicine, Biology, Biochemistry, Internal medicine, Bacteria, Mathematics, Statistics, Ecology, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
57Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4412164474 |
|---|---|
| doi | https://doi.org/10.1371/journal.pone.0328167 |
| ids.doi | https://doi.org/10.1371/journal.pone.0328167 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40638652 |
| ids.openalex | https://openalex.org/W4412164474 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | Q000187 |
| mesh[0].descriptor_ui | D018441 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | drug effects |
| mesh[0].descriptor_name | Biofilms |
| mesh[1].qualifier_ui | Q000254 |
| mesh[1].descriptor_ui | D018441 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | growth & development |
| mesh[1].descriptor_name | Biofilms |
| mesh[2].qualifier_ui | Q000382 |
| mesh[2].descriptor_ui | D062885 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | microbiology |
| mesh[2].descriptor_name | Urinary Catheters |
| mesh[3].qualifier_ui | Q000517 |
| mesh[3].descriptor_ui | D014552 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | prevention & control |
| mesh[3].descriptor_name | Urinary Tract Infections |
| mesh[4].qualifier_ui | Q000382 |
| mesh[4].descriptor_ui | D014552 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | microbiology |
| mesh[4].descriptor_name | Urinary Tract Infections |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D006801 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Humans |
| mesh[6].qualifier_ui | Q000517 |
| mesh[6].descriptor_ui | D055499 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | prevention & control |
| mesh[6].descriptor_name | Catheter-Related Infections |
| mesh[7].qualifier_ui | Q000382 |
| mesh[7].descriptor_ui | D055499 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | microbiology |
| mesh[7].descriptor_name | Catheter-Related Infections |
| mesh[8].qualifier_ui | Q000494 |
| mesh[8].descriptor_ui | D020099 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | pharmacology |
| mesh[8].descriptor_name | Coated Materials, Biocompatible |
| mesh[9].qualifier_ui | Q000494 |
| mesh[9].descriptor_ui | D000900 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | pharmacology |
| mesh[9].descriptor_name | Anti-Bacterial Agents |
| mesh[10].qualifier_ui | Q000187 |
| mesh[10].descriptor_ui | D018441 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | drug effects |
| mesh[10].descriptor_name | Biofilms |
| mesh[11].qualifier_ui | Q000254 |
| mesh[11].descriptor_ui | D018441 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | growth & development |
| mesh[11].descriptor_name | Biofilms |
| mesh[12].qualifier_ui | Q000382 |
| mesh[12].descriptor_ui | D062885 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | microbiology |
| mesh[12].descriptor_name | Urinary Catheters |
| mesh[13].qualifier_ui | Q000517 |
| mesh[13].descriptor_ui | D014552 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | prevention & control |
| mesh[13].descriptor_name | Urinary Tract Infections |
| mesh[14].qualifier_ui | Q000382 |
| mesh[14].descriptor_ui | D014552 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | microbiology |
| mesh[14].descriptor_name | Urinary Tract Infections |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D006801 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Humans |
| mesh[16].qualifier_ui | Q000517 |
| mesh[16].descriptor_ui | D055499 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | prevention & control |
| mesh[16].descriptor_name | Catheter-Related Infections |
| mesh[17].qualifier_ui | Q000382 |
| mesh[17].descriptor_ui | D055499 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | microbiology |
| mesh[17].descriptor_name | Catheter-Related Infections |
| mesh[18].qualifier_ui | Q000494 |
| mesh[18].descriptor_ui | D020099 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | pharmacology |
| mesh[18].descriptor_name | Coated Materials, Biocompatible |
| mesh[19].qualifier_ui | Q000494 |
| mesh[19].descriptor_ui | D000900 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | pharmacology |
| mesh[19].descriptor_name | Anti-Bacterial Agents |
| type | article |
| title | LubriShieldTM—A permanent urinary catheter coating that prevents uropathogen biofilm formation in vitro independent of host protein conditioning |
| awards[0].id | https://openalex.org/G4634952213 |
| awards[0].funder_id | https://openalex.org/F4320337754 |
| awards[0].display_name | |
| awards[0].funder_award_id | 826846 |
| awards[0].funder_display_name | Competitiveness of Enterprises and Small and Medium-sized Enterprises |
| awards[1].id | https://openalex.org/G5543378109 |
| awards[1].funder_id | https://openalex.org/F4320321030 |
| awards[1].display_name | |
| awards[1].funder_award_id | 2019-05644 |
| awards[1].funder_display_name | VINNOVA |
| biblio.issue | 7 |
| biblio.volume | 20 |
| biblio.last_page | e0328167 |
| biblio.first_page | e0328167 |
| topics[0].id | https://openalex.org/T11232 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Urinary Tract Infections Management |
| topics[1].id | https://openalex.org/T10428 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9922000169754028 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2404 |
| topics[1].subfield.display_name | Microbiology |
| topics[1].display_name | Reproductive tract infections research |
| topics[2].id | https://openalex.org/T13849 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9904000163078308 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1310 |
| topics[2].subfield.display_name | Endocrinology |
| topics[2].display_name | Enterobacteriaceae and Cronobacter Research |
| funders[0].id | https://openalex.org/F4320321030 |
| funders[0].ror | https://ror.org/01kd5m353 |
| funders[0].display_name | VINNOVA |
| funders[1].id | https://openalex.org/F4320337754 |
| funders[1].ror | |
| funders[1].display_name | Competitiveness of Enterprises and Small and Medium-sized Enterprises |
| is_xpac | False |
| apc_list.value | 1805 |
| apc_list.currency | USD |
| apc_list.value_usd | 1805 |
| apc_paid.value | 1805 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1805 |
| concepts[0].id | https://openalex.org/C58123911 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8442069292068481 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q467410 |
| concepts[0].display_name | Biofilm |
| concepts[1].id | https://openalex.org/C202751555 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5509914755821228 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[1].display_name | In vitro |
| concepts[2].id | https://openalex.org/C2993006401 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5465946793556213 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1025432 |
| concepts[2].display_name | Urinary catheter |
| concepts[3].id | https://openalex.org/C89423630 |
| concepts[3].level | 1 |
| concepts[3].score | 0.489717036485672 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[3].display_name | Microbiology |
| concepts[4].id | https://openalex.org/C185592680 |
| concepts[4].level | 0 |
| concepts[4].score | 0.4657866060733795 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[4].display_name | Chemistry |
| concepts[5].id | https://openalex.org/C45262634 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4620378017425537 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q5159291 |
| concepts[5].display_name | Conditioning |
| concepts[6].id | https://openalex.org/C77411442 |
| concepts[6].level | 2 |
| concepts[6].score | 0.45506569743156433 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q181100 |
| concepts[6].display_name | Urinary system |
| concepts[7].id | https://openalex.org/C126831891 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4354398548603058 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q221673 |
| concepts[7].display_name | Host (biology) |
| concepts[8].id | https://openalex.org/C71924100 |
| concepts[8].level | 0 |
| concepts[8].score | 0.3652019500732422 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[8].display_name | Medicine |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.2301115095615387 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C55493867 |
| concepts[10].level | 1 |
| concepts[10].score | 0.17304813861846924 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[10].display_name | Biochemistry |
| concepts[11].id | https://openalex.org/C126322002 |
| concepts[11].level | 1 |
| concepts[11].score | 0.16052380204200745 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[11].display_name | Internal medicine |
| concepts[12].id | https://openalex.org/C523546767 |
| concepts[12].level | 2 |
| concepts[12].score | 0.10568463802337646 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q10876 |
| concepts[12].display_name | Bacteria |
| concepts[13].id | https://openalex.org/C33923547 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q395 |
| concepts[13].display_name | Mathematics |
| concepts[14].id | https://openalex.org/C105795698 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12483 |
| concepts[14].display_name | Statistics |
| concepts[15].id | https://openalex.org/C18903297 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7150 |
| concepts[15].display_name | Ecology |
| concepts[16].id | https://openalex.org/C54355233 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[16].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/biofilm |
| keywords[0].score | 0.8442069292068481 |
| keywords[0].display_name | Biofilm |
| keywords[1].id | https://openalex.org/keywords/in-vitro |
| keywords[1].score | 0.5509914755821228 |
| keywords[1].display_name | In vitro |
| keywords[2].id | https://openalex.org/keywords/urinary-catheter |
| keywords[2].score | 0.5465946793556213 |
| keywords[2].display_name | Urinary catheter |
| keywords[3].id | https://openalex.org/keywords/microbiology |
| keywords[3].score | 0.489717036485672 |
| keywords[3].display_name | Microbiology |
| keywords[4].id | https://openalex.org/keywords/chemistry |
| keywords[4].score | 0.4657866060733795 |
| keywords[4].display_name | Chemistry |
| keywords[5].id | https://openalex.org/keywords/conditioning |
| keywords[5].score | 0.4620378017425537 |
| keywords[5].display_name | Conditioning |
| keywords[6].id | https://openalex.org/keywords/urinary-system |
| keywords[6].score | 0.45506569743156433 |
| keywords[6].display_name | Urinary system |
| keywords[7].id | https://openalex.org/keywords/host |
| keywords[7].score | 0.4354398548603058 |
| keywords[7].display_name | Host (biology) |
| keywords[8].id | https://openalex.org/keywords/medicine |
| keywords[8].score | 0.3652019500732422 |
| keywords[8].display_name | Medicine |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.2301115095615387 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/biochemistry |
| keywords[10].score | 0.17304813861846924 |
| keywords[10].display_name | Biochemistry |
| keywords[11].id | https://openalex.org/keywords/internal-medicine |
| keywords[11].score | 0.16052380204200745 |
| keywords[11].display_name | Internal medicine |
| keywords[12].id | https://openalex.org/keywords/bacteria |
| keywords[12].score | 0.10568463802337646 |
| keywords[12].display_name | Bacteria |
| language | en |
| locations[0].id | doi:10.1371/journal.pone.0328167 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S202381698 |
| locations[0].source.issn | 1932-6203 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1932-6203 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | PLoS ONE |
| locations[0].source.host_organization | https://openalex.org/P4310315706 |
| locations[0].source.host_organization_name | Public Library of Science |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315706 |
| locations[0].source.host_organization_lineage_names | Public Library of Science |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | PLOS One |
| locations[0].landing_page_url | https://doi.org/10.1371/journal.pone.0328167 |
| locations[1].id | pmid:40638652 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | PloS one |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40638652 |
| locations[2].id | pmh:oai:doaj.org/article:44da59ef917f47c7b761272c041d8cd6 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | PLoS ONE, Vol 20, Iss 7, p e0328167 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/44da59ef917f47c7b761272c041d8cd6 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:12244716 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | PLoS One |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12244716 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5024403082 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3630-3113 |
| authorships[0].author.display_name | Ana I. Romero |
| authorships[0].countries | SE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210136433 |
| authorships[0].affiliations[0].raw_affiliation_string | CytaCoat AB, Solna, Sweden. |
| authorships[0].institutions[0].id | https://openalex.org/I4210136433 |
| authorships[0].institutions[0].ror | https://ror.org/03ges2v44 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210136433 |
| authorships[0].institutions[0].country_code | SE |
| authorships[0].institutions[0].display_name | CytaCoat (Sweden) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ana I Romero |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | CytaCoat AB, Solna, Sweden. |
| authorships[1].author.id | https://openalex.org/A5006672873 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Serhiy Surkov |
| authorships[1].countries | SE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210136433 |
| authorships[1].affiliations[0].raw_affiliation_string | CytaCoat AB, Solna, Sweden. |
| authorships[1].institutions[0].id | https://openalex.org/I4210136433 |
| authorships[1].institutions[0].ror | https://ror.org/03ges2v44 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210136433 |
| authorships[1].institutions[0].country_code | SE |
| authorships[1].institutions[0].display_name | CytaCoat (Sweden) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Serhiy Surkov |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | CytaCoat AB, Solna, Sweden. |
| authorships[2].author.id | https://openalex.org/A5116035291 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Per Wirsén |
| authorships[2].countries | SE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210136433 |
| authorships[2].affiliations[0].raw_affiliation_string | CytaCoat AB, Solna, Sweden. |
| authorships[2].institutions[0].id | https://openalex.org/I4210136433 |
| authorships[2].institutions[0].ror | https://ror.org/03ges2v44 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210136433 |
| authorships[2].institutions[0].country_code | SE |
| authorships[2].institutions[0].display_name | CytaCoat (Sweden) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Per Wirsén |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | CytaCoat AB, Solna, Sweden. |
| authorships[3].author.id | https://openalex.org/A5112799389 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Graham Brookes |
| authorships[3].countries | SE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210136433 |
| authorships[3].affiliations[0].raw_affiliation_string | CytaCoat AB, Solna, Sweden. |
| authorships[3].institutions[0].id | https://openalex.org/I4210136433 |
| authorships[3].institutions[0].ror | https://ror.org/03ges2v44 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210136433 |
| authorships[3].institutions[0].country_code | SE |
| authorships[3].institutions[0].display_name | CytaCoat (Sweden) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Graeme Brookes |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | CytaCoat AB, Solna, Sweden. |
| authorships[4].author.id | https://openalex.org/A5110825100 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Linda Bergström |
| authorships[4].countries | SE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210136433 |
| authorships[4].affiliations[0].raw_affiliation_string | CytaCoat AB, Solna, Sweden. |
| authorships[4].institutions[0].id | https://openalex.org/I4210136433 |
| authorships[4].institutions[0].ror | https://ror.org/03ges2v44 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210136433 |
| authorships[4].institutions[0].country_code | SE |
| authorships[4].institutions[0].display_name | CytaCoat (Sweden) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Linda Bergström |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | CytaCoat AB, Solna, Sweden. |
| authorships[5].author.id | https://openalex.org/A5116035292 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Jan Tejbrant |
| authorships[5].countries | SE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210136433 |
| authorships[5].affiliations[0].raw_affiliation_string | CytaCoat AB, Solna, Sweden. |
| authorships[5].institutions[0].id | https://openalex.org/I4210136433 |
| authorships[5].institutions[0].ror | https://ror.org/03ges2v44 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210136433 |
| authorships[5].institutions[0].country_code | SE |
| authorships[5].institutions[0].display_name | CytaCoat (Sweden) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Jan Tejbrant |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | CytaCoat AB, Solna, Sweden. |
| authorships[6].author.id | https://openalex.org/A5072782150 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Elena Dhamo |
| authorships[6].countries | SE |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210136433 |
| authorships[6].affiliations[0].raw_affiliation_string | CytaCoat AB, Solna, Sweden. |
| authorships[6].institutions[0].id | https://openalex.org/I4210136433 |
| authorships[6].institutions[0].ror | https://ror.org/03ges2v44 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210136433 |
| authorships[6].institutions[0].country_code | SE |
| authorships[6].institutions[0].display_name | CytaCoat (Sweden) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Elena Dhamo |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | CytaCoat AB, Solna, Sweden. |
| authorships[7].author.id | https://openalex.org/A5067204485 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4134-9415 |
| authorships[7].author.display_name | Sandra Wilks |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I43439940 |
| authorships[7].affiliations[0].raw_affiliation_string | School of Biological Sciences, University of Southampton, Southampton, United Kingdom. |
| authorships[7].institutions[0].id | https://openalex.org/I43439940 |
| authorships[7].institutions[0].ror | https://ror.org/01ryk1543 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I43439940 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | University of Southampton |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Sandra Wilks |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | School of Biological Sciences, University of Southampton, Southampton, United Kingdom. |
| authorships[8].author.id | https://openalex.org/A5108390427 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-6142-0688 |
| authorships[8].author.display_name | Catherine Bryant |
| authorships[8].countries | GB |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I43439940 |
| authorships[8].affiliations[0].raw_affiliation_string | School of Biological Sciences, University of Southampton, Southampton, United Kingdom. |
| authorships[8].institutions[0].id | https://openalex.org/I43439940 |
| authorships[8].institutions[0].ror | https://ror.org/01ryk1543 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I43439940 |
| authorships[8].institutions[0].country_code | GB |
| authorships[8].institutions[0].display_name | University of Southampton |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Catherine Bryant |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | School of Biological Sciences, University of Southampton, Southampton, United Kingdom. |
| authorships[9].author.id | https://openalex.org/A5078542779 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-0316-3860 |
| authorships[9].author.display_name | Jan Andersson |
| authorships[9].countries | SE |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I28166907 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Medicine, Karolinska Institutet, Stockholm, Sweden. |
| authorships[9].institutions[0].id | https://openalex.org/I28166907 |
| authorships[9].institutions[0].ror | https://ror.org/056d84691 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[9].institutions[0].country_code | SE |
| authorships[9].institutions[0].display_name | Karolinska Institutet |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Jan Andersson |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Medicine, Karolinska Institutet, Stockholm, Sweden. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1371/journal.pone.0328167 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | LubriShieldTM—A permanent urinary catheter coating that prevents uropathogen biofilm formation in vitro independent of host protein conditioning |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-08T23:21:52.890332 |
| primary_topic.id | https://openalex.org/T11232 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Urinary Tract Infections Management |
| related_works | https://openalex.org/W2012553523, https://openalex.org/W4409428905, https://openalex.org/W3201679234, https://openalex.org/W4249343127, https://openalex.org/W2039975600, https://openalex.org/W2320192779, https://openalex.org/W2154378279, https://openalex.org/W2038205245, https://openalex.org/W1998444747, https://openalex.org/W2209704440 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1371/journal.pone.0328167 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S202381698 |
| best_oa_location.source.issn | 1932-6203 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1932-6203 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | PLoS ONE |
| best_oa_location.source.host_organization | https://openalex.org/P4310315706 |
| best_oa_location.source.host_organization_name | Public Library of Science |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315706 |
| best_oa_location.source.host_organization_lineage_names | Public Library of Science |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | PLOS One |
| best_oa_location.landing_page_url | https://doi.org/10.1371/journal.pone.0328167 |
| primary_location.id | doi:10.1371/journal.pone.0328167 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S202381698 |
| primary_location.source.issn | 1932-6203 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1932-6203 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | PLoS ONE |
| primary_location.source.host_organization | https://openalex.org/P4310315706 |
| primary_location.source.host_organization_name | Public Library of Science |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315706 |
| primary_location.source.host_organization_lineage_names | Public Library of Science |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | PLOS One |
| primary_location.landing_page_url | https://doi.org/10.1371/journal.pone.0328167 |
| publication_date | 2025-07-10 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2120088134, https://openalex.org/W1985840130, https://openalex.org/W2123097137, https://openalex.org/W2053769493, https://openalex.org/W2080074875, https://openalex.org/W2480010979, https://openalex.org/W4392083342, https://openalex.org/W1989804346, https://openalex.org/W2131727615, https://openalex.org/W1998453329, https://openalex.org/W2122836009, https://openalex.org/W2115772223, https://openalex.org/W2158573840, https://openalex.org/W2076405992, https://openalex.org/W2171782979, https://openalex.org/W3196712884, https://openalex.org/W2144675324, https://openalex.org/W2898252491, https://openalex.org/W3081176487, https://openalex.org/W2998839559, https://openalex.org/W2012691775, https://openalex.org/W2020354602, https://openalex.org/W2991573081, https://openalex.org/W1981882990, https://openalex.org/W3001267719, https://openalex.org/W2922936472, https://openalex.org/W3136701994, https://openalex.org/W2102278945, https://openalex.org/W2104005232, https://openalex.org/W2170551349, https://openalex.org/W1999574084, https://openalex.org/W2119034410, https://openalex.org/W2146516445, https://openalex.org/W182884414, https://openalex.org/W2159907987, https://openalex.org/W1537509539, https://openalex.org/W2148998200, https://openalex.org/W3106145816, https://openalex.org/W2320825661, https://openalex.org/W2611388424, https://openalex.org/W2129028806, https://openalex.org/W2156333255, https://openalex.org/W2040098801, https://openalex.org/W2601158968, https://openalex.org/W2036517794, https://openalex.org/W2127170059, https://openalex.org/W2783397133, https://openalex.org/W2779795038, https://openalex.org/W2792847166, https://openalex.org/W3131491068, https://openalex.org/W1907384058, https://openalex.org/W2156788471, https://openalex.org/W170995186, https://openalex.org/W2029738070, https://openalex.org/W2593273109, https://openalex.org/W1825440375, https://openalex.org/W2949574248 |
| referenced_works_count | 57 |
| abstract_inverted_index.% | 190 |
| abstract_inverted_index.( | 214, 256 |
| abstract_inverted_index.. | 194 |
| abstract_inverted_index.= | 216, 258 |
| abstract_inverted_index.P | 171, 215, 257 |
| abstract_inverted_index.a | 16, 61, 73, 85, 108, 144, 176, 206, 244 |
| abstract_inverted_index.(P | 191 |
| abstract_inverted_index.). | 174, 218, 260 |
| abstract_inverted_index.14 | 158 |
| abstract_inverted_index.83 | 189 |
| abstract_inverted_index.In | 175 |
| abstract_inverted_index.TM | 106, 182, 240 |
| abstract_inverted_index.To | 101 |
| abstract_inverted_index.by | 97, 188 |
| abstract_inverted_index.in | 19, 63, 160 |
| abstract_inverted_index.is | 4 |
| abstract_inverted_index.it | 133 |
| abstract_inverted_index.of | 6, 57, 66, 124, 224 |
| abstract_inverted_index.on | 231, 253 |
| abstract_inverted_index.to | 37, 42, 47, 54, 118, 157, 168, 210, 238, 248, 251 |
| abstract_inverted_index.up | 156 |
| abstract_inverted_index.(up | 167 |
| abstract_inverted_index.78% | 245 |
| abstract_inverted_index.99% | 169 |
| abstract_inverted_index.EPS | 229 |
| abstract_inverted_index.The | 140 |
| abstract_inverted_index.and | 33, 51, 80, 94, 115, 121 |
| abstract_inverted_index.for | 31, 76, 155 |
| abstract_inverted_index.its | 20, 198 |
| abstract_inverted_index.key | 17 |
| abstract_inverted_index.one | 5 |
| abstract_inverted_index.the | 7, 29, 64, 232 |
| abstract_inverted_index.was | 113 |
| abstract_inverted_index.– | 107, 112 |
| abstract_inverted_index.< | 172, 192 |
| abstract_inverted_index.This | 71 |
| abstract_inverted_index.When | 49 |
| abstract_inverted_index.body | 30 |
| abstract_inverted_index.both | 119 |
| abstract_inverted_index.days | 159 |
| abstract_inverted_index.even | 201 |
| abstract_inverted_index.flow | 179 |
| abstract_inverted_index.form | 65 |
| abstract_inverted_index.from | 137, 152 |
| abstract_inverted_index.mode | 56 |
| abstract_inverted_index.most | 8 |
| abstract_inverted_index.role | 18 |
| abstract_inverted_index.they | 59 |
| abstract_inverted_index.this | 103 |
| abstract_inverted_index.with | 12, 204, 227 |
| abstract_inverted_index.0.001 | 173 |
| abstract_inverted_index.0.004 | 259 |
| abstract_inverted_index.0.007 | 217 |
| abstract_inverted_index.Foley | 127 |
| abstract_inverted_index.after | 202 |
| abstract_inverted_index.cells | 82 |
| abstract_inverted_index.fluid | 98 |
| abstract_inverted_index.fungi | 52 |
| abstract_inverted_index.genes | 225 |
| abstract_inverted_index.glass | 177 |
| abstract_inverted_index.ideal | 26 |
| abstract_inverted_index.known | 209 |
| abstract_inverted_index.novel | 109 |
| abstract_inverted_index.often | 40 |
| abstract_inverted_index.shear | 99 |
| abstract_inverted_index.still | 183 |
| abstract_inverted_index.those | 252 |
| abstract_inverted_index.tract | 2 |
| abstract_inverted_index.urine | 162 |
| abstract_inverted_index.while | 83 |
| abstract_inverted_index.(EPS). | 70 |
| abstract_inverted_index.active | 131 |
| abstract_inverted_index.agents | 93 |
| abstract_inverted_index.coated | 233, 241 |
| abstract_inverted_index.common | 9 |
| abstract_inverted_index.evenly | 116 |
| abstract_inverted_index.immune | 89 |
| abstract_inverted_index.inside | 28 |
| abstract_inverted_index.matrix | 62 |
| abstract_inverted_index.medium | 163 |
| abstract_inverted_index.model, | 180 |
| abstract_inverted_index.severe | 43 |
| abstract_inverted_index.showed | 243 |
| abstract_inverted_index.switch | 53 |
| abstract_inverted_index.system | 90 |
| abstract_inverted_index.unique | 74 |
| abstract_inverted_index.0.0001) | 193 |
| abstract_inverted_index.RNA-seq | 219 |
| abstract_inverted_index.Without | 129 |
| abstract_inverted_index.address | 102 |
| abstract_inverted_index.against | 88 |
| abstract_inverted_index.applied | 117 |
| abstract_inverted_index.barrier | 87 |
| abstract_inverted_index.biofilm | 13, 38, 55, 154, 186 |
| abstract_inverted_index.bladder | 178 |
| abstract_inverted_index.coating | 111 |
| abstract_inverted_index.creates | 72 |
| abstract_inverted_index.devices | 24 |
| abstract_inverted_index.feature | 34 |
| abstract_inverted_index.forces. | 100 |
| abstract_inverted_index.forming | 84, 153 |
| abstract_inverted_index.growing | 77 |
| abstract_inverted_index.growth, | 58 |
| abstract_inverted_index.killing | 166 |
| abstract_inverted_index.leading | 41 |
| abstract_inverted_index.ligand, | 147 |
| abstract_inverted_index.medical | 23 |
| abstract_inverted_index.playing | 15 |
| abstract_inverted_index.produce | 60 |
| abstract_inverted_index.promote | 211 |
| abstract_inverted_index.protein | 208 |
| abstract_inverted_index.reduced | 185 |
| abstract_inverted_index.removal | 96 |
| abstract_inverted_index.urinary | 1, 126 |
| abstract_inverted_index.without | 164 |
| abstract_inverted_index.adhering | 237 |
| abstract_inverted_index.analysis | 220 |
| abstract_inverted_index.attacks, | 91 |
| abstract_inverted_index.bacteria | 50 |
| abstract_inverted_index.biofilm. | 139 |
| abstract_inverted_index.clinical | 44 |
| abstract_inverted_index.coating, | 142 |
| abstract_inverted_index.compared | 250 |
| abstract_inverted_index.efficacy | 200 |
| abstract_inverted_index.external | 122 |
| abstract_inverted_index.internal | 120 |
| abstract_inverted_index.invented | 114 |
| abstract_inverted_index.pathways | 27 |
| abstract_inverted_index.revealed | 221 |
| abstract_inverted_index.surfaces | 35, 123 |
| abstract_inverted_index.uncoated | 254 |
| abstract_inverted_index.virulent | 78 |
| abstract_inverted_index.bacterial | 212 |
| abstract_inverted_index.catheters | 242, 255 |
| abstract_inverted_index.conducive | 36 |
| abstract_inverted_index.formation | 14, 187, 230 |
| abstract_inverted_index.increased | 246 |
| abstract_inverted_index.infection | 3 |
| abstract_inverted_index.inhibited | 149 |
| abstract_inverted_index.introduce | 25 |
| abstract_inverted_index.microbial | 165, 228 |
| abstract_inverted_index.pathogens | 32, 136 |
| abstract_inverted_index.permanent | 110 |
| abstract_inverted_index.polymeric | 68 |
| abstract_inverted_index.prevented | 135 |
| abstract_inverted_index.producing | 138 |
| abstract_inverted_index.releasing | 130 |
| abstract_inverted_index.shielding | 86 |
| abstract_inverted_index.surfaces. | 234 |
| abstract_inverted_index.Indwelling | 22 |
| abstract_inverted_index.artificial | 161 |
| abstract_inverted_index.associated | 226 |
| abstract_inverted_index.attachment | 213 |
| abstract_inverted_index.catheters. | 128 |
| abstract_inverted_index.challenge, | 104 |
| abstract_inverted_index.colonisers | 79 |
| abstract_inverted_index.colonising | 150 |
| abstract_inverted_index.indwelling | 125 |
| abstract_inverted_index.infections | 45 |
| abstract_inverted_index.maintained | 197 |
| abstract_inverted_index.mechanical | 95 |
| abstract_inverted_index.persisting | 81 |
| abstract_inverted_index.reduction, | 170 |
| abstract_inverted_index.substances | 69 |
| abstract_inverted_index.LubriShield | 105, 181, 239 |
| abstract_inverted_index.antibiofilm | 199 |
| abstract_inverted_index.antibiotics | 249 |
| abstract_inverted_index.effectively | 134 |
| abstract_inverted_index.environment | 75 |
| abstract_inverted_index.fibrinogen, | 205 |
| abstract_inverted_index.infections, | 11 |
| abstract_inverted_index.proprietary | 145 |
| abstract_inverted_index.significant | 222 |
| abstract_inverted_index.substances, | 132 |
| abstract_inverted_index.Importantly, | 195 |
| abstract_inverted_index.anti-fouling | 146 |
| abstract_inverted_index.conditioning | 203 |
| abstract_inverted_index.development, | 39 |
| abstract_inverted_index.host-derived | 207 |
| abstract_inverted_index.recalcitrant | 46 |
| abstract_inverted_index.uropathogens | 151 |
| abstract_inverted_index.Additionally, | 235 |
| abstract_inverted_index.antimicrobial | 92 |
| abstract_inverted_index.extracellular | 67 |
| abstract_inverted_index.incorporating | 143 |
| abstract_inverted_index.pathogenesis. | 21 |
| abstract_inverted_index.significantly | 148, 184 |
| abstract_inverted_index.LubriShield™ | 196 |
| abstract_inverted_index.downregulation | 223 |
| abstract_inverted_index.microorganisms | 236 |
| abstract_inverted_index.susceptibility | 247 |
| abstract_inverted_index.antimicrobials. | 48 |
| abstract_inverted_index.superhydrophilic | 141 |
| abstract_inverted_index.Catheter-associated | 0 |
| abstract_inverted_index.healthcare-associated | 10 |
| cited_by_percentile_year | |
| countries_distinct_count | 2 |
| institutions_distinct_count | 10 |
| citation_normalized_percentile.value | 0.36897202 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |